HEPATOCELLULAR CARCINOMA [neop]    
Hepatitis C carrier [fndg]    
NORMAL [qlco]    
Alanine Aminotransferase level [lbtr]    
Aims [idcn]    
Study [mnob]    
Independent [idcn]    
Risk Factors [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
chronic Hepatitis C virus infection [dsyn]    
NORMAL [qlco]    
ALT [neop]    
Levels [qlco]    
Methods [inpr]    
Patients [podg]    
Average [qnco]    
ALT [neop]    
Integration [genf]    
Values [qlco]    
Equal [qlco]    
IU/L [qnco]    
YEARS [tmco]    
included [ftcn]    
baseline [bodm]    
ULTRASOUND [diap]    
Patients [podg]    
Patients [podg]    
Liver Biopsy [diap]    
Start [tmco]    
Study [mnob]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
HEPATOCELLULAR CARCINOMA [neop]    
Occurred [acty]    
Patients [podg]    
Following [tmco]    
HEPATOCELLULAR CARCINOMA [neop]    
YEARS [tmco]    
Adjusted [ftcn]    
Hazard Ratio [qnco]    
ALT [neop]    
IU/L [qnco]    
Platelet Count [lbpr]    
mg dl [qnco]    
ALP [gngm]    
IU/L [qnco]    
3 5 [qnco]    
DI [gngm]    
YEAR [tmco]    
Cumulative [qlco]    
Incidences [qnco]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
ALT [neop]    
IU/L [qnco]    
Platelet Count [lbpr]    
Conclusions [idcn]    
ALT [neop]    
Low platelet count [fndg]    
Hepatocarcinogenesis [neop]    
Group [idcn]    
Antiviral Therapy [topp]    
EUROPEAN [popg]    
Association [menp]    
Study [mnob]    
LIVER [bpoc]    
Published [ocac]    
rights [qlco]    
Reserve [acty]    
